Early-life exposure to methylmercury in wildtype and pdr-1/parkin knockout C. elegans

Neurochemical Research

Volumn 38, Issue 8, 2013, Pages 1543-1552

  Martinez Finley, Ebany J ^a,b   Chakraborty, Sudipta ^b   Slaughter, James C ^a   Aschner, Michael ^a,b  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Dopamine; Early life exposure; Large amino acid transporter; Methylmercury; Parkin

Indexed keywords

METHYLMERCURY; PARKIN; REACTIVE OXYGEN METABOLITE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CAENORHABDITIS ELEGANS; CONTROLLED STUDY; DISEASE EXACERBATION; DOPAMINERGIC SYSTEM; EARLY LIFE STRESS; GENE; GENE INDUCTION; GENE SILENCING; GENETIC TRANSCRIPTION; GENOTYPE ENVIRONMENT INTERACTION; LETHALITY; LIFESPAN; NEUROTOXICITY; NONHUMAN; PARKIN GENE; PDE 1 GENE; PRIORITY JOURNAL; SKN 1 GENE; WILD TYPE;

ANIMALS; BASE SEQUENCE; CAENORHABDITIS ELEGANS; DNA PRIMERS; ENVIRONMENTAL EXPOSURE; MASS SPECTROMETRY; METHYLMERCURY COMPOUNDS; REACTIVE OXYGEN SPECIES; REAL-TIME POLYMERASE CHAIN REACTION; UBIQUITIN-PROTEIN LIGASES;

CAENORHABDITIS ELEGANS; MAMMALIA;

EID: 84879689165     PISSN: 03643190     EISSN: 15736903     Source Type: Journal    
DOI: 10.1007/s11064-013-1054-8     Document Type: Article

References (39)

1. Gorell JM et al (1999) Occupational metal exposures and the risk of Parkinson's disease. Neuroepidemiology 18(6):303-308
2. Kirkey KL et al (2001) Occupational categories at risk for Parkinson's disease. Am J Ind Med 39(6):564-571
3. Ngim CH, Devathasan G (1989) Epidemiologic study on the association between body burden mercury level and idiopathic Parkinson's disease. Neuroepidemiology 8(3):128-141
4. Wermuth L et al (2008) Prevalence and incidence of Parkinson's disease in The Faroe Islands. Acta Neurol Scand 118(2):126-131
5. Brooks AI et al (1999) Paraquat elicited neurobehavioral syndrome caused by dopaminergic neuron loss. Brain Res 823(1-2):1-10
6. McCormack AL et al (2002) Environmental risk factors and Parkinson's disease: selective degeneration of nigral dopaminergic neurons caused by the herbicide paraquat. Neurobiol Dis 10(2):119-127
7. Kitada T et al (1998) Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392(6676):605-608
8. Mizuno Y et al (2001) Parkin and Parkinson's disease. Curr Opin Neurol 14(4):477-482
9. Springer W et al (2005) A Caenorhabditis elegans Parkin mutant with altered solubility couples alpha-synuclein aggregation to proteotoxic stress. Hum Mol Genet 14(22):3407-3423
10. Sulston J, Dew M, Brenner S (1975) Dopaminergic neurons in the nematode Caenorhabditis elegans. J Comp Neurol 163(2):215-226
11. Sawin ER, Ranganathan R, Horvitz HR (2000) C. elegans locomotory rate is modulated by the environment through a dopaminergic pathway and by experience through a serotonergic pathway. Neuron 26(3):619-631
12. Bartolome J et al (1984) Exposure to methylmercury in utero: effects on biochemical development of catecholamine neurotransmitter systems. Life Sci 35(6):657-670
13. Dreiem A et al (2009) Methylmercury inhibits dopaminergic function in rat pup synaptosomes in an age-dependent manner. Neurotoxicol Teratol 31(5):312-317
14. Petersen MS et al (2008) Increased prenatal exposure to methylmercury does not affect the risk of Parkinson's disease. Neurotoxicology 29(4):591-595
15. Castoldi AF et al (2006) Brain monoaminergic neurotransmission parameters in weanling rats after perinatal exposure to methylmercury and 2,2′,4,4′,5,5′-hexachlorobiphenyl (PCB153). Brain Res 1112(1):91-98
16. Dare E et al (2003) Effects of prenatal exposure to methylmercury on dopamine-mediated locomotor activity and dopamine D2 receptor binding. Naunyn Schmiedebergs Arch Pharmacol 367(5):500-508
17. Fujimura M et al (2009) Methylmercury exposure downregulates the expression of Racl and leads to neuritic degeneration and ultimately apoptosis in cerebrocortical neurons. Neurotoxicology 30(1):16-22
18. Vanduyn N et al (2010) SKN-1/Nrf2 inhibits dopamine neuron degeneration in a Caenorhabditis elegans model of methylmercury toxicity. Toxicol Sci 118(2):613-624
19. Boado RJ, Li JY, Pardridge WM (2004) Developmental regulation of the rabbit blood-brain barrier LAT1 large neutral amino acid transporter mRNA and protein. Pediatr Res 55(4):557-560
20. Kerper LE, Ballatori N, Clarkson TW (1992) Methylmercury transport across the blood-brain barrier by an amino acid carrier. Am J Physiol 262(5 Pt 2):R761-R765
21. Yin Z et al (2008) The methylmercury-l-cysteine conjugate is a substrate for the L-type large neutral amino acid transporter. J Neurochem 107(4):1083-1090
22. Veljkovic E et al (2004) Functional characterization of Caenorhabditis elegans heteromeric amino acid transporters. J Biol Chem 279(9):7655-7662
23. Helmcke KJ et al (2009) Characterization of the effects of methylmercury on Caenorhabditis elegans. Toxicol Appl Pharmacol 240(2):265-272
24. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25(4):402-408
25. Goulet S, Dore FY, Mirault ME (2003) Neurobehavioral changes in mice chronically exposed to methylmercury during fetal and early postnatal development. Neurotoxicol Teratol 25(3):335-347
26. Saini N et al (2010) Extended lifespan of Drosophila parkin mutants through sequestration of redox-active metals and enhancement of anti-oxidative pathways. Neurobiol Dis 40(1):82-92
27. Itier JM et al (2003) Parkin gene inactivation alters behaviour and dopamine neurotransmission in the mouse. Hum Mol Genet 12(18):2277-2291
28. Roth JA et al (2010) Parkin regulates metal transport via proteasomal degradation of the 1B isoforms of divalent metal transporter 1. J Neurochem 113(2):454-464
29. Ni M et al (2010) Methylmercury induces acute oxidative stress, altering Nrf2 protein level in primary microglial cells. Toxicol Sci 116(2):590-603
30. Hyun DH et al (2005) Effect of overexpression of wild-type or mutant parkin on the cellular response induced by toxic insults. J Neurosci Res 82(2):232-244
31. Jenner P (1998) Oxidative mechanisms in nigral cell death in Parkinson's disease. Mov Disord 13(Suppl 1):24-34
32. Jiang H et al (2004) Parkin protects human dopaminergic neuroblastoma cells against dopamine-induced apoptosis. Hum Mol Genet 13(16):1745-1754
33. Finkel T, Holbrook NJ (2000) Oxidants, oxidative stress and the biology of ageing. Nature 408(6809):239-247
34. Lithgow GJ, Walker GA (2002) Stress resistance as a determinate of C. elegans lifespan. Mech Ageing Dev 123(7):765-771
35. An JH, Blackwell TK (2003) SKN-1 links C. elegans mesendodermal specification to a conserved oxidative stress response. Genes Dev 17(15):1882-1893
36. Imaizumi Y et al (2012) Mitochondrial dysfunction associated with increased oxidative stress and alpha-synuclein accumulation in PARK2 iPSC-derived neurons and postmortem brain tissue. Mol Brain 5(1):35
37. Helmcke KJ, Aschner M (2010) Hormetic effect of methylmercury on Caenorhabditis elegans. Toxicol Appl Pharmacol 248(2):156-164
38. Bramanti E et al (1999) Application of mercury cold vapor atomic fluorescence spectrometry to the characterization of mercury-accessible-SH groups in native proteins. Anal Biochem 274(2):163-173
39. Oyama G et al (2010) Impaired in vivo dopamine release in parkin knockout mice. Brain Res 1352:214-222